Impact Of Oral Ubiquinol On Blood Oxidative Stress And Exercise Performance
Notes for this study:
||BPM. Mean and SEM. At 8 minutes in treadmill test: Placebo: 122.2 ± 5.7 Intervention: 119.9 ± 6.4 At 14 minutes: Placebo: 147.1 ± 5.0 intervention 148.2 ± 6.5. Cycling: Placebo: 156.4 ± 3.2 Coq10: 155.6 ± 3.6
|Number of Subjects
In a randomized, double-blind, crossover trial, 15 exercise-trained participants took 300 mg of ubiquinol daily and placebo for four weeks, separated by a 3-week washout period. Participants maintained their exercise routines and were subjected to graded exercise tests on treadmills and cycle sprint tests on a cycle ergometer.
Funding issues for this study:
There were no statistically significant differences in heart rate, perceived exertion, or time on the treadmill test, and no statistically significant differences in heart rate, perceived exertion, peak power, mean power, or total work on the cycling test. There were no statistically significant differences in malondialdehyde, hydrogen peroxide, or total cholesterol at rest, nor were there statistically significant differences in malondialdehyde, hydrogen peroxide, or lactate during the exercise tests.
"Financial support for this work was provided by Kaneka Nutrients (Pasdena, TX). The investigators and the University of Memphis have no direct or indirect interest in the tested product (Kaneka QH) or in Kaneka Nutrients."